55 results
8-K
EX-99.1
EQ
Equillium Inc
8 Mar 24
Departure of Directors or Certain Officers
4:01pm
in which the Company or the Affiliate is domiciled or incorporated, as the case may be.
(e) Change in Time Commitment. In the event a Participant’s … regular level of time commitment in the performance of such Participant’s services for the Company and any Affiliates is reduced (for example, and without
PRE 14A
n04ju2
31 Mar 23
Preliminary proxy
4:02pm
425
nq6kb i56rtpcz4p2p
6 Dec 22
Business combination disclosure
7:02am
8-K
EX-99.1
jd8ghajnv
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
424B3
3z7fxwxcto01girg1
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
ikf 6381ht
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
wcf6r
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
ez97g
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-2.1
3hc0l2tf
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K/A
EX-99.1
qj44kt2ir
2 May 22
Financial Statements and Exhibits
1:19pm
8-K/A
EX-99.2
77u5x
2 May 22
Financial Statements and Exhibits
1:19pm